36-kDa Annexin A3 Isoform Negatively Modulates Lipid Storage in Clear Cell Renal Cell Carcinoma Cells.


Journal

The American journal of pathology
ISSN: 1525-2191
Titre abrégé: Am J Pathol
Pays: United States
ID NLM: 0370502

Informations de publication

Date de publication:
11 2020
Historique:
received: 04 03 2020
revised: 28 07 2020
accepted: 18 08 2020
pubmed: 31 8 2020
medline: 2 12 2020
entrez: 31 8 2020
Statut: ppublish

Résumé

The adipocyte-like morphology of clear cell renal cell carcinoma (ccRCC) cells results from a grade-dependent neutral lipid accumulation; however, the molecular mechanism and role in renal cancer progression have yet to be clarified. ccRCC shows a gene expression signature consistent with adipogenesis, and the phospholipid-binding protein annexin A3 (AnxA3), a negative regulator of adipocyte differentiation, is down-regulated in RCC and shows a differential expression pattern for two isoforms of 36 and 33 kDa. Using primary cell cultures and cell lines, we investigated the involvement of AnxA3 isoforms in lipid storage modulation of ccRCC cells. We found that the increased accumulation of lipids into ccRCC cells correlated with a decrease of the 36/33 isoform ratio. Treatment with adipogenic medium induced a significant increment of lipid storage in ccRCC cells that had a low 36-kDa AnxA3 expression and 36/33 ratio. The 36-kDa AnxA3 silencing in ccRCC cells increased lipid storage induced by adipogenic medium. These data suggest that 36-kDa AnxA3 negatively modulates the response to adipogenic treatment and may act as negative regulator of lipid storage in ccRCC cells. The subcellular distribution of AnxA3 in the cellular endocytic compartment suggests its involvement in modulation of vesicular trafficking, and it might serve as a putative mechanism of lipid storage regulation in ccRCC cells, opening novel translational outcomes.

Identifiants

pubmed: 32861643
pii: S0002-9440(20)30381-3
doi: 10.1016/j.ajpath.2020.08.008
pii:
doi:

Substances chimiques

ANXA3 protein, human 0
Isoenzymes 0
Neoplasm Proteins 0
Annexin A3 EC 3.1.4.43

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2317-2326

Informations de copyright

Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Auteurs

Silvia Bombelli (S)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

Barbara Torsello (B)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

Sofia De Marco (S)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

Giuseppe Lucarelli (G)

Department of Emergency and Organ Transplantation-Urology, University of Bari, Bari, Italy.

Ingrid Cifola (I)

Institute for Biomedical Technologies, National Research Council, Segrate, Italy.

Chiara Grasselli (C)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

Guido Strada (G)

Urology Unit, ASST North Milan, Bassini Hospital, Cinisello Balsamo, Italy.

Giorgio Bovo (G)

Pathology Unit, ASST North Milan, Vimercate Hospital, Vimercate, Italy.

Roberto A Perego (RA)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy. Electronic address: cristina.bianchi@unimib.it.

Cristina Bianchi (C)

School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy. Electronic address: roberto.perego@unimib.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH